GGrantIndex
← Leaderboards

Daniel I Simon

Brigham And Women'S Hospital

$14,441,938
Attributed
$14,441,938
Total exposure
6
Grants
6
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).

Funding over time

peak $942.6K · FY200525
$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$14,441,938 · 6

By mechanism

R01$7,599,517 · 4
R37$4,060,388 · 1
P01$2,782,033 · 1

Top collaborators

No co-investigators on record.

Most similar at Brigham And Women'S Hospital

Same institution · by research overlap

Others in their field

Top investigators on “Inflammation

Research focus

InflammationLeukocytesIntegrinsBlood PlateletsComplexAtherosclerosisMolecularThrombosisInsightSignal TransductionMediatingReceptorBaseBlood VesselsIn VivoInflammatoryLaboratoriesReportingResponseLasersMonocyteGenerationsCellsBinding Sites

Grant awards (34)

Project 3- Role of Leukocyte-Platelet Interactions in Inflammation and Thrombosis$563,501
P01 · FY2025 · HL · contact PI
Project 3- Role of Leukocyte-Platelet Interactions in Inflammation and Thrombosis$555,400
P01 · FY2024 · HL · contact PI
Project 3- Role of Leukocyte-Platelet Interactions in Inflammation and Thrombosis$563,501
P01 · FY2023 · HL · contact PI
Project 3- Role of Leukocyte-Platelet Interactions in Inflammation and Thrombosis$563,501
P01 · FY2022 · HL · contact PI
Project 3- Role of Leukocyte-Platelet Interactions in Inflammation and Thrombosis$536,130
P01 · FY2021 · HL · contact PI
MRP-14, CD36 and Thrombosis$505,093
R01 · FY2019 · HL · contact PI
MRP-14, CD36 and Thrombosis$505,093
R01 · FY2018 · HL · contact PI
MRP-14, CD36 and Thrombosis$505,093
R01 · FY2017 · HL · contact PI
MRP-14, CD36 and Thrombosis$519,718
R01 · FY2016 · HL · contact PI
Inflammation in Vascular Injury and Repair$422,847
R37 · FY2016 · HL · contact PI
Inflammation in Vascular Injury and Repair$416,503
R37 · FY2015 · HL · contact PI
Inflammation in Vascular Injury and Repair$414,391
R37 · FY2014 · HL · contact PI
Inflammation in Vascular Injury and Repair$402,550
R37 · FY2013 · HL · contact PI
Inflammation in Vascular Injury and Repair$472,847
R37 · FY2012 · HL · contact PI
Inflammation in Vascular Injury and Repair$386,250
R37 · FY2011 · HL · contact PI
MRP-14 and Cardiovascular Disease$388,770
R01 · FY2010 · HL · contact PI
Inflammation in Vascular Injury and Repair$386,250
R37 · FY2010 · HL · contact PI
MRP-14 and Cardiovascular Disease$388,770
R01 · FY2009 · HL · contact PI
Inflammation in Vascular Injury and Repair$386,250
R37 · FY2009 · HL · contact PI
MRP-14 and Cardiovascular Disease$390,669
R01 · FY2008 · HL · contact PI
Inflammation in Vascular Injury and Repair$386,250
R37 · FY2008 · HL · contact PI
MRP-14 and Cardiovascular Disease$400,496
R01 · FY2007 · HL · contact PI
Inflammation in Vascular Injury and Repair$386,250
R37 · FY2007 · HL · contact PI
Monocyte Differentiation and Mac-1-Regulated Forkhead$369,900
R01 · FY2006 · HL · contact PI
Inflammation in Vascular Injury and Repair$339,457
R01 · FY2006 · HL · contact PI
Monocyte Differentiation and Mac-1-Regulated Forkhead$410,600
R01 · FY2005 · HL
Inflammation in Vascular Injury and Repair$362,970
R01 · FY2005 · HL
Monocyte Differentiation and Mac-1-Regulated Forkhead$410,600
R01 · FY2004 · HL
Inflammation in Vascular Injury and Repair$362,970
R01 · FY2004 · HL
Monocyte Differentiation and Mac-1-Regulated Forkhead$410,600
R01 · FY2003 · HL
Inflammation in Vascular Injury and Repair$362,970
R01 · FY2003 · HL
Inflammation in Vascular Injury and Repair$362,498
R01 · FY2002 · HL
FIBRINOGEN, INFLAMMATION, AND ATHEROGENESIS$304,016
R01 · FY2001 · HL
FIBRINOGEN, INFLAMMATION, AND ATHEROGENESIS$299,234
R01 · FY2000 · HL